In this episode of the GTSC podcast, Dr. Dennis Wigle (Mayo Clinic) and Dr. Linda Martin (UVA) review the recently published ALINA trial of adjuvant alectinib for resected ALK-positive NSCLC. We also review recently presented lung and esophageal cancer data from ASCO 2024, including ESOPEC, CheckMate 816 and 77T, AEGEAN, and the LU002 trial results for oligometastatic lung cancer. This podcast is sponsored by Genentech.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör General Thoracic Surgical Club. Innehållet i podden är skapat av General Thoracic Surgical Club och inte av, eller tillsammans med, Poddtoppen.